CLINICAL IMPORTANCE OF ENDOTHELIAL DYSFUNCTION AND INSULIN RESISTANCE SYNDROME IN PATIENTS WITH GOUT ASSOCIATED WITH ARTERIAL HYPERTENSION
https://doi.org/10.20996/1819-6446-2013-9-5-482-487
Abstract
Aim. To study the endothelium status and determine the correlation between endothelial dysfunction and glucose metabolism in men with gout associated with arterial hypertension (HT).
Material and methods. Patients (n=175, all are males) with gout were enrolled into the study. Ambulatory blood pressure monitoring (ABPM) was performed in all patients. Endothelial function was studied in tests with reactive hyperemia (endothelium-dependent reaction) and nitroglycerin (endothelium independent reaction) in brachial artery by ultrasonic Doppler examination. The level of nitrite-nitrate and endothelin-1 in blood serum was determined by ELISA technique. Fasting blood glucose and oral glucose tolerance tests were performed as well as fasting insulin blood level was determined by immunoenzyme method. Insulin-resistance index (HOMA-IR) was calculated. Patients with HOMA- IR>2.77 were considered as insulin-resistant.
Results. Patients with gout demonstrated endothelial deterioration associated with activation of nitroxid producing function, elevation in endothelin-1 serum level (1.36 fmol/ml [0.91; 2.32 fmol/ml] vs 0.19 fmol/ml [0.16; 0.27 fmol/ml] in controls, p<0.05) and impairments of endothelium-dependent vasodilation (6.4% [3.3; 7.3%] vs 17.8% [12.7; 23.9%] in controls, p<0.05). The revealed changes were the most marked in patients with gout associated with HT. The correlation between some endothelial dysfunction in- dices and glucose metabolism was observed.
Conclusion. ABPM, brachial artery endothelium-dependent vasodilation and glucose metabolism status should be studied in patients with gout. Complex treatment of cardiovascular diseases in patients with gout should include ω-3 polyunsaturated fatty acids, angiotensin receptor antagonists should be used for antihypertensive therapy.
About the Authors
N. N. KushnarenkoRussian Federation
A. V. Govorin
Russian Federation
References
1. Kotovshikova E.F., Sulzhina E.N., Buevich E.I., Veretennikova L.S. Endothelial dysfunction indices in acute myocardial infarction. Siberia Medical Journal (Ircutsk) 2011; (1): 46-7. Russian (Котовщикова Е.Ф., Сюльжина Е.Н., Буевич Е.И., Веретенникова Л.С. Маркеры дисфункции эндотелия при остром инфаркте миокарда. Сибирский медицинский журнал (Иркутск) 2011; (1): 46-7).
2. Namakanov B.A., Rasulov M.M. Endothelial dysfunction in arterial hypertension – risk factor for cardiovascular complications. Cardiovascular Therapy and Prevention 2005; 4(6): 98-101. Russian (Намаканов Б.А., Расулов М.М. Эндотелиальная дисфункция при артериальной гипертонии – фактор риска сердечно-сосудистых осложнений. Кардиоваскулярная Терапия и Профилактика 2005; 4(6): 98-101).
3. Petrishev N.N., Vlasov T.D. Physiology and pathologic physiology of endothelium. // N.N. Petrishev Dysfunction of endothelium. Causes, mechanisms, pharmacologic correction. Saint Petersburg: St.PSMU;
4. Russian (Петрищев Н.Н., Власов Т.Д. Физиология и патофизиология эндотелия. В кн.: Петрищев Н.Н. Дисфункция эндотелия. Причины, механизмы, фармакологическая коррекция. СПб.: Изд-во СПбГМУ; 2003).
5. Furchgott R.F., Vanhoutte P.M. Еndothelium-derived relaxing and contracting factors. FASEB J. 1989; 3: 2007-18.
6. Nebieridze D.V. Endothelial dysfunction and its management in arterial hypertension. Russia Medical Journal 2006; 2(254): 127-31. Russian (Небиеридзе Д.В. Дисфункция эндотелия и ее коррекция при артериальной гипертонии. Русский медицинский журнал. 2006; 2(254): 127-31).
7. Lapkina N.A., Baranov A.A., Barskova V.G. et al. Endothelia activation markers in gout. Ther arkhiv 2005; (6): 62-5. Russian (Лапкина Н.А., Баранов А.А., Барскова В.Г. Маркеры активации эндотелия при подагре. Тер архив 2005; (6): 62-5).
8. Urazalina S.Zh., Titov V.N., Balakhonova T.V. et al. Correlation of uric acid and subclinic atherosclerotic disturbances of arterial wall. Cardiologic Vestnik 2011; (2): 31-7. Russian (Уразалина С.Ж., Титов В.Н., Балахонова Т.В. и др. Взаимосвязь мочевой кислоты с параметрами субклинического атеросклеротического поражения артериальной стенки. Кардиологический вестник. 2011; (2): 31-7).
9. Kanellis J., Kang D.H. Uric acid as a mediator of endothelial dysfunction, inflammation and vascular diseas. Semin Nephrol 2005; 25: 39-42.
10. Kuznik B.I. Cellular and molecule mechanisms of hemostasis regulation in health and disease. – Chita: Express-publication; 2010. Russian (Кузник Б.И. Клеточные и молекулярные механизмы регуляции системы гемостаза в норме и патологии. Чита: Экспресс-издательство; 2010).
11. Laakso M., Sarlund H., Mykkanen L. Insulin resistance is associated with lipid and lipoprotein abnormalities in subject with varying degrees of glucose tolerance. Arteriosclerosis 1990; 10: 223-231.
12. Wallace К.L., Riedel A.A., Joseph-Ridge N. et al. Increasing prevalence of gout and hyperuricemia over 10 years among older adult in a managed care population. J Rheumatol 2004; 31: 1582-87.
13. Myers M.G., Haynes R.B., Rabkin S.W. Canadian hypertension society guidelines for ambulatory blood pressure monitoring. Am J Hypertens 1999; 11: 1149-57.
14. Ivanova O.V., Rogosa A.N., Balakhonova T.V. et al. Determination of the braehial artery sensitivity to transverse strain on endothelium as an assessment method of endothelium-dependent vasodilatation by Doplerography in patients with arterial hypertension. Kardiologiia 1998; (3): 37-41. Russian (Иванова О.В., Рогоза А.Н., Балахонова Т.В. и др. Определение чувствительности плечевой артерии к напряжению сдвига на эндотелии как метод оценки состояния эндотелий-зависимой вазодилатации с помощью ультразвука высокого разрешения у больных с артериальной гипертонией. Кардиология 1998; (3): 37-41).
15. Hollenbeck C. B., Chen N., Chen Y. D. I., Reaven G.М. Relationship between the plasma insulin response to oral glucose and insulin-stimulated glucose utilization in normal subjects. Diabetes 1984; 33: 460-463.
16. Roitberg G.E. Metabolic syndrome. Moscow: MEDpress-inform; 2007. Russian (Ройтберг Г.Е. Метаболический синдром. Москва: МЕДпресс-информ; 2007).
17. Zateitshikova A.A., Zateitshikov D.A. Endothelial regulation of vascular tone: methods and clinical value. Kardiologiia 1998; (9): 68-76. Russian (Затейщикова А.А., Затейщиков Д.А. Эндотелиальная регуляция сосудистого тонуса: методы исследования и клиническое значение. Кардиология 1998; (9): 68-76).
18. ESH-ESC Guidelines Committee. ESH-ESC guidelines for the management of arterial hypertension. J Hypertens 2007; 21: 1011-53.
19. Martynov A.I., Avetyak N.A., Akatova E.V. et al. Endothelial dysfunction and method of its diagnosis. Russia Cardiologic Journal 2005; (4): 94-8. Russian (Мартынов А.И., Аветяк Н.Г., Акатова Е.В. и др. Эндотелиальная дисфункция и методы ее определения. Российский Кардиологический Журнал 2005; (4): 94-8).
20. Lebedeva M.V., Stakhova T.J., Minakova E.G., et al. Endothelial function in patients with arterial hypertension and impaired uric acid metabolism. Vestnik RAMS 2010; (12): 44-46. Russian (Лебедева М.В., Стахова Т.Ю., Минакова Е.Г., и др. Функция эндотелия у больных с артериальной гипертензией и нарушением обмена мочевой кислоты. Вестник Российской АМН 2010; 12: 44-46)
21. Herman J.B., Goldbord U. Uric acid and diabetes: observations in a population study. Lancet 1982; 2: 240-3.
22. Fam A.G. Gout, diet, and the insulin resistance syndrome. J Rheumatol 2002; 29: 1350-5.
Review
For citations:
Kushnarenko N.N., Govorin A.V. CLINICAL IMPORTANCE OF ENDOTHELIAL DYSFUNCTION AND INSULIN RESISTANCE SYNDROME IN PATIENTS WITH GOUT ASSOCIATED WITH ARTERIAL HYPERTENSION. Rational Pharmacotherapy in Cardiology. 2013;9(5):482-487. (In Russ.) https://doi.org/10.20996/1819-6446-2013-9-5-482-487